Though PEDF is a potent anti-angiogenic factor [53], pancreatic cancer-associated hypovasculatory and hypoxia are not likely mediated by PEDF, given that most patients have significantly reduced levels of PEDF. The gene discussed is SERPINF1; the disease is pancreatic neoplasm.